Biogen Agrees To Develop Knopp's Experimental ALS Drug
Biogen has partnered with Knopp Neurosciences to push forward the development of dexpramipexole, a drug which has shown promise in preserving motor function and extending survival of ALS patients. The deal for control of the orphan drug...